Elevance Health (MIL:1ANTM) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1ANTM Elevance Health Inc MIL:1ANTM
90 GF Score
Price €355.00
GF Value €395.16
! 7 Warning Signs
View Full Analysis

What is Elevance Health Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Elevance Health  (MIL:1ANTM) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Elevance Health Cyclically Adjusted PS Ratio Related Terms


Elevance Health Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Elevance Health's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elevance Health Cyclically Adjusted PS Ratio Chart

Elevance Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.76 0.53

Elevance Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.61 0.50 0.53 0.44 0.57

MIL:1ANTM vs CI, CVS, HUM: Cyclically Adjusted PS Ratio Comparison

For the Healthcare Plans subindustry, Elevance Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elevance Health Cyclically Adjusted PS Ratio vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Elevance Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Elevance Health's Cyclically Adjusted PS Ratio falls into.


MIL:1ANTM
90GF Score
Elevance Health Inc MIL:1ANTM
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elevance Health Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Elevance Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Elevance Health's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=199.223/333.9520*333.9520
=199.223

Current CPI (Jun. 2026) = 333.9520.

Elevance Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 71.572 241.428 99.001
201612 74.984 241.432 103.719
201703 78.162 243.801 107.064
201706 75.191 244.955 102.509
201709 71.563 246.819 96.826
201712 73.159 246.524 99.104
201803 69.779 249.554 93.378
201806 72.805 251.989 96.486
201809 75.321 252.439 99.642
201812 77.530 251.233 103.057
201903 82.818 254.202 108.800
201906 86.835 256.143 113.213
201909 92.273 256.759 120.014
201912 95.948 256.974 124.690
202003 104.865 258.115 135.675
202006 104.048 257.797 134.784
202009 104.934 260.280 134.635
202012 106.307 260.474 136.296
202103 108.328 264.877 136.578
202106 113.583 271.696 139.609
202109 123.527 274.310 150.385
202112 130.362 278.802 156.149
202203 138.944 287.504 161.391
202206 148.931 296.311 167.850
202209 163.709 296.808 184.196
202212 162.392 296.797 182.721
202303 163.976 301.836 181.423
202306 168.741 305.109 184.693
202309 166.541 307.789 180.697
202312 168.218 306.746 183.138
202403 167.501 312.332 179.096
202406 173.697 314.175 184.631
202409 176.299 315.301 186.728
202412 184.339 315.605 195.055
202503 204.463 319.799 213.512
202506 194.488 322.561 201.356
202509 193.982 324.800 199.448
202512 192.698 324.054 198.584
202603 194.612 330.213 196.816
202606 199.223 333.952 199.223

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Elevance Health (MIL:1ANTM) Overvalued in 2026?

Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued. The current stock price of €355.00 is trading 10.2% below its estimated GF Value™ of €395.16.

Key valuation signals for MIL:1ANTM:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €395.16 vs. price of €355.00 (10.2% below fair value)
  • GF Score™: 90/100 with 7 warning signs

No single metric tells the full story. See the MIL:1ANTM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Elevance Health Business Description

Address 220 Virginia Avenue, Indianapolis, IN, USA, 46204
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
90GF Score

Get the complete analysis for MIL:1ANTM

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€355.00
Price
€395.16
GF Value